Skip to content
10-Q

Quarterly Report

Anthera Pharmaceuticals Inc

0001214659-18-003764

← back to feed
Filed
May 15, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2018 · Apr 30, 2018 26.18M sh
Operating Cash Flow Q1 2018 · Mar 31, 2018 −$9.38M
Operating Cash Flow Q1 2018 · Mar 31, 2017 −$14.33M
Cash And Equivalents Q1 2018 · Mar 31, 2018 $8.09M
Cash And Equivalents Q1 2018 · Dec 31, 2017 $2.2M
Cash And Equivalents Q1 2018 · Mar 31, 2017 $20.65M
Cash And Equivalents Q1 2018 · Dec 31, 2016 $20.84M
Stockholders Equity Q1 2018 · Mar 31, 2018 $5.46M
Stockholders Equity Q1 2018 · Dec 31, 2017 −$5.5M
Current Liabilities Q1 2018 · Mar 31, 2018 $2.65M
Current Liabilities Q1 2018 · Dec 31, 2017 $4.71M
Total Liabilities Q1 2018 · Mar 31, 2018 $3.35M
Total Liabilities Q1 2018 · Dec 31, 2017 $9.17M
Current Assets Q1 2018 · Mar 31, 2018 $8.74M
Current Assets Q1 2018 · Dec 31, 2017 $3.19M
Total Assets Q1 2018 · Mar 31, 2018 $8.81M
Total Assets Q1 2018 · Dec 31, 2017 $3.67M
Sga Expense Q1 2018 · Mar 31, 2018 $3.5M
Sga Expense Q1 2018 · Mar 31, 2017 $2.9M
Rd Expense Q1 2018 · Mar 31, 2018 $7.47M
Rd Expense Q1 2018 · Mar 31, 2017 $7.8M
Net Income Q1 2018 · Mar 31, 2018 −$7.72M
Net Income Q1 2018 · Mar 31, 2017 −$11.21M
Operating Income Q1 2018 · Mar 31, 2018 −$10.97M
Operating Income Q1 2018 · Mar 31, 2017 −$10.6M